You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -13,731.3% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -4.0 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 909.2 | 0.0 |
| Price / Book value | 8.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -37.5% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | n/a | -10.06 | -12.62p | -63.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | n/a | -11.71 | -15.21p | -46.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -23.99 | -26.08p | -12.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -28.44 | -36.17p | -2.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.21 | -29.43 | -36.75p | -2.7 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 0.00 | -31.50 | -19.39p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 15.40 | -20.30 | -10.50p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Next part of tumour trial begins for 4D Pharma Sharecast News | 06 Jul |
|---|---|
| Patient enrolment begins for 4D's Covid therapy candidate Sharecast News | 02 Jul |
| 4D Pharma receives expedited approval for coronavirus study Sharecast News | 20 Apr |
| Interim Results | 30-Sep-20 07:04 |
|---|---|
| Directorate Change | 23-Sep-20 07:06 |
| Block Listing Six Monthly Return | 14-Sep-20 16:30 |
| Holding(s) in Company | 07-Sep-20 17:27 |
| MRx0158 Keytruda Part A clinical benefit data | 26-Aug-20 07:05 |